489 related articles for article (PubMed ID: 29570475)
1. Tocilizumab in Giant Cell Arteritis.
Mariano VJ; Frishman WH
Cardiol Rev; 2018; 26(6):321-330. PubMed ID: 29570475
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Villiger PM; Adler S; Kuchen S; Wermelinger F; Dan D; Fiege V; Bütikofer L; Seitz M; Reichenbach S
Lancet; 2016 May; 387(10031):1921-7. PubMed ID: 26952547
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab in the treatment of giant cell arteritis.
Leuchten N; Aringer M
Immunotherapy; 2018 Mar; 10(6):465-472. PubMed ID: 29504436
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and biological efficacy of tocilizumab in giant cell arteritis: report of three patients and literature review].
Kieffer P; Hinschberger O; Ciobanu E; Jaeger-Bizet F; Drabo A; Mostoufizadeh T; Martzolff L
Rev Med Interne; 2014 Jan; 35(1):56-9. PubMed ID: 24075627
[TBL] [Abstract][Full Text] [Related]
5. Tocilizumab for the treatment of giant cell arteritis.
Schirmer M; Muratore F; Salvarani C
Expert Rev Clin Immunol; 2018 May; 14(5):339-349. PubMed ID: 29676602
[TBL] [Abstract][Full Text] [Related]
6. Trial of Tocilizumab in Giant-Cell Arteritis.
Stone JH; Tuckwell K; Dimonaco S; Klearman M; Aringer M; Blockmans D; Brouwer E; Cid MC; Dasgupta B; Rech J; Salvarani C; Schett G; Schulze-Koops H; Spiera R; Unizony SH; Collinson N
N Engl J Med; 2017 Jul; 377(4):317-328. PubMed ID: 28745999
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and tolerance of tocilizumab for corticosteroid sparing in giant cell arteritis and aortitis: Experience of Nimes University Hospital about eleven patients].
Broner J; Arnaud E
Rev Med Interne; 2018 Feb; 39(2):78-83. PubMed ID: 29221884
[TBL] [Abstract][Full Text] [Related]
8. Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients.
Régent A; Redeker S; Deroux A; Kieffer P; Ly KH; Dougados M; Liozon E; Larroche C; Guillevin L; Bouillet L; Espitia O; Costedoat-Chalumeau N; Soubrier M; Brihaye B; Lifermann F; Lefevre G; Puéchal X; Mouthon L; Toussirot E;
J Rheumatol; 2016 Aug; 43(8):1547-52. PubMed ID: 27182063
[TBL] [Abstract][Full Text] [Related]
9. The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study.
Kreis L; Dejaco C; Schmidt WA; Németh R; Venhoff N; Schäfer VS
Trials; 2024 Jan; 25(1):56. PubMed ID: 38225579
[TBL] [Abstract][Full Text] [Related]
10. Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.
Vitiello G; Orsi Battaglini C; Carli G; Radice A; Matucci A; Vultaggio A; Olianti C; Parronchi P; Maggi E; Cammelli D
Angiology; 2018 Oct; 69(9):763-769. PubMed ID: 29343075
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab for relapsing and remitting giant cell arteritis: a case series.
Saha P; Srikantharajah D; Kaul A; Sofat N
J Med Case Rep; 2022 Oct; 16(1):389. PubMed ID: 36289554
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of tocilizumab in refractory giant cell arteritis.
Vinit J; Bielefeld P; Muller G; Besancenot JF
Joint Bone Spine; 2012 May; 79(3):317-8. PubMed ID: 22284606
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab for giant cell arteritis with corticosteroid-resistant progressive anterior ischemic optic neuropathy.
Vionnet J; Buss G; Mayer C; Sokolov AA; Borruat FX; Spertini F
Joint Bone Spine; 2017 Oct; 84(5):615-619. PubMed ID: 28499892
[TBL] [Abstract][Full Text] [Related]
14. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.
Calderón-Goercke M; Loricera J; Aldasoro V; Castañeda S; Villa I; Humbría A; Moriano C; Romero-Yuste S; Narváez J; Gómez-Arango C; Pérez-Pampín E; Melero R; Becerra-Fernández E; Revenga M; Álvarez-Rivas N; Galisteo C; Sivera F; Olivé-Marqués A; Álvarez Del Buergo M; Marena-Rojas L; Fernández-López C; Navarro F; Raya E; Galindez-Agirregoikoa E; Arca B; Solans-Laqué R; Conesa A; Hidalgo C; Vázquez C; Román-Ivorra JA; Lluch P; Manrique-Arija S; Vela P; De Miguel E; Torres-Martín C; Nieto JC; Ordas-Calvo C; Salgado-Pérez E; Luna-Gomez C; Toyos-Sáenz de Miera FJ; Fernández-Llanio N; García A; Larena C; Palmou-Fontana N; Calvo-Río V; Prieto-Peña D; González-Vela C; Corrales A; Varela-García M; Aurrecoechea E; Dos Santos R; García-Manzanares Á; Ortego N; Fernández S; Ortiz-Sanjuán F; Corteguera M; Hernández JL; González-Gay MÁ; Blanco R
Semin Arthritis Rheum; 2019 Aug; 49(1):126-135. PubMed ID: 30655091
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab: a novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases.
Alten R; Maleitzke T
Ann Med; 2013 Jun; 45(4):357-63. PubMed ID: 23650978
[TBL] [Abstract][Full Text] [Related]
16. The role of biologics in the treatment of giant cell arteritis.
González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
Expert Opin Biol Ther; 2019 Jan; 19(1):65-72. PubMed ID: 30513026
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
18. Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept study.
Unizony S; Matza MA; Jarvie A; O'Dea D; Fernandes AD; Stone JH
Lancet Rheumatol; 2023 Dec; 5(12):e736-e742. PubMed ID: 38251564
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients.
Loricera J; Blanco R; Hernández JL; Castañeda S; Mera A; Pérez-Pampín E; Peiró E; Humbría A; Calvo-Alén J; Aurrecoechea E; Narváez J; Sánchez-Andrade A; Vela P; Díez E; Mata C; Lluch P; Moll C; Hernández Í; Calvo-Río V; Ortiz-Sanjuán F; González-Vela C; Pina T; González-Gay MÁ
Semin Arthritis Rheum; 2015 Jun; 44(6):717-23. PubMed ID: 25697557
[TBL] [Abstract][Full Text] [Related]
20. Giant cell arteritis: An updated review of an old disease.
Rinden T; Miller E; Nasr R
Cleve Clin J Med; 2019 Jul; 86(7):465-472. PubMed ID: 31291180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
